Market Share of Anti-fungal Drugs Industry
The analyzed market is moderately competitive, primarily due to the presence of a limited number of smaller players and several major industry players. The market participants are actively engaged in launching new products and obtaining approvals for them, which is anticipated further to intensify the competitive environment within the studied market. Among the significant market players are Abbott Laboratories, Bayer AG, Astellas Pharma Inc., Glenmark Pharmaceuticals Limited, GSK plc, Merck & Co. Inc., Novartis AG, Pfizer Inc, and others.
Anti-Fungal Drugs Market Leaders
Abbott Laboratories
Bayer AG
Merck & Co., Inc.
Glenmark Pharmaceuticals Limited
GSK plc
*Disclaimer: Major Players sorted in no particular order